Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AvroBio
Biotech
Avrobio's corporate tremor attracts Tectonic for reverse merger
Tectonic has raised a $130.7 million private placement to jump-start its pipeline following a merger with Avrobio.
Max Bayer
Jan 30, 2024 3:24pm
Avrobio stops programs, halves head count and searches for exit
Jul 12, 2023 8:00am
Novartis to buy Avrobio gene therapy for $88M, ending M&A rumor
May 22, 2023 8:55am
Avrobio hopes to get investors back on gene therapy bandwagon
Dec 7, 2022 7:30am
Avrobio CEO shares outlook on cell and gene landscape
Sep 30, 2022 12:02pm
Avrobio gene therapy shows signs of durability in rare disorder
Feb 9, 2022 10:46am
